Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups

B. Sis, M. Mengel, M. Haas, R. B. Colvin, P. F. Halloran, L. C. Racusen, K. Solez, W. M. Baldwin, E. R. Bracamonte, V. Broecker, F. Cosio, A. J. Demetris, C. Drachenberg, G. Einecke, J. Gloor, D. Glotz, E. Kraus, C. Legendre, H. Liapis, R. B. MannonB. J. Nankivell, V. Nickeleit, J. C. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, E. R. Rodriguez, D. Seron, S. Seshan, Manikkam Suthanthiran, B. A. Wasowska, A. Zachary, A. Zeevi

Research output: Contribution to journalArticle

554 Citations (Scopus)

Abstract

The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.

Original languageEnglish
Pages (from-to)464-471
Number of pages8
JournalAmerican Journal of Transplantation
Volume10
Issue number3
DOIs
Publication statusPublished - 1 Jan 2010
Externally publishedYes

Fingerprint

Transplants
Antibodies
Biopsy
Polyomavirus
Molecular Pathology
Quality Improvement
Research
Mental Competency
Multicenter Studies
Canada
Allografts
Reading
Microscopy
Fibrosis
Research Personnel
Pathology
Technology
Wounds and Injuries
Pathologists
Surgeons

Keywords

  • Acute allograft rejection
  • Acute cellular rejection
  • Acute rejection
  • Allograft rejection
  • Antibody mediated rejection
  • Banff
  • Banff lesions
  • Banff schema
  • Chronic allograft rejection
  • Classification
  • Donor specific antibody
  • GeneChip
  • Genomic markers

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Banff '09 meeting report : Antibody mediated graft deterioration and implementation of Banff working groups. / Sis, B.; Mengel, M.; Haas, M.; Colvin, R. B.; Halloran, P. F.; Racusen, L. C.; Solez, K.; Baldwin, W. M.; Bracamonte, E. R.; Broecker, V.; Cosio, F.; Demetris, A. J.; Drachenberg, C.; Einecke, G.; Gloor, J.; Glotz, D.; Kraus, E.; Legendre, C.; Liapis, H.; Mannon, R. B.; Nankivell, B. J.; Nickeleit, V.; Papadimitriou, J. C.; Randhawa, P.; Regele, H.; Renaudin, K.; Rodriguez, E. R.; Seron, D.; Seshan, S.; Suthanthiran, Manikkam; Wasowska, B. A.; Zachary, A.; Zeevi, A.

In: American Journal of Transplantation, Vol. 10, No. 3, 01.01.2010, p. 464-471.

Research output: Contribution to journalArticle

Sis, B, Mengel, M, Haas, M, Colvin, RB, Halloran, PF, Racusen, LC, Solez, K, Baldwin, WM, Bracamonte, ER, Broecker, V, Cosio, F, Demetris, AJ, Drachenberg, C, Einecke, G, Gloor, J, Glotz, D, Kraus, E, Legendre, C, Liapis, H, Mannon, RB, Nankivell, BJ, Nickeleit, V, Papadimitriou, JC, Randhawa, P, Regele, H, Renaudin, K, Rodriguez, ER, Seron, D, Seshan, S, Suthanthiran, M, Wasowska, BA, Zachary, A & Zeevi, A 2010, 'Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups', American Journal of Transplantation, vol. 10, no. 3, pp. 464-471. https://doi.org/10.1111/j.1600-6143.2009.02987.x
Sis, B. ; Mengel, M. ; Haas, M. ; Colvin, R. B. ; Halloran, P. F. ; Racusen, L. C. ; Solez, K. ; Baldwin, W. M. ; Bracamonte, E. R. ; Broecker, V. ; Cosio, F. ; Demetris, A. J. ; Drachenberg, C. ; Einecke, G. ; Gloor, J. ; Glotz, D. ; Kraus, E. ; Legendre, C. ; Liapis, H. ; Mannon, R. B. ; Nankivell, B. J. ; Nickeleit, V. ; Papadimitriou, J. C. ; Randhawa, P. ; Regele, H. ; Renaudin, K. ; Rodriguez, E. R. ; Seron, D. ; Seshan, S. ; Suthanthiran, Manikkam ; Wasowska, B. A. ; Zachary, A. ; Zeevi, A. / Banff '09 meeting report : Antibody mediated graft deterioration and implementation of Banff working groups. In: American Journal of Transplantation. 2010 ; Vol. 10, No. 3. pp. 464-471.
@article{dfa5601efab24695b555aed0bef64ce7,
title = "Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups",
abstract = "The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.",
keywords = "Acute allograft rejection, Acute cellular rejection, Acute rejection, Allograft rejection, Antibody mediated rejection, Banff, Banff lesions, Banff schema, Chronic allograft rejection, Classification, Donor specific antibody, GeneChip, Genomic markers",
author = "B. Sis and M. Mengel and M. Haas and Colvin, {R. B.} and Halloran, {P. F.} and Racusen, {L. C.} and K. Solez and Baldwin, {W. M.} and Bracamonte, {E. R.} and V. Broecker and F. Cosio and Demetris, {A. J.} and C. Drachenberg and G. Einecke and J. Gloor and D. Glotz and E. Kraus and C. Legendre and H. Liapis and Mannon, {R. B.} and Nankivell, {B. J.} and V. Nickeleit and Papadimitriou, {J. C.} and P. Randhawa and H. Regele and K. Renaudin and Rodriguez, {E. R.} and D. Seron and S. Seshan and Manikkam Suthanthiran and Wasowska, {B. A.} and A. Zachary and A. Zeevi",
year = "2010",
month = "1",
day = "1",
doi = "10.1111/j.1600-6143.2009.02987.x",
language = "English",
volume = "10",
pages = "464--471",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Banff '09 meeting report

T2 - Antibody mediated graft deterioration and implementation of Banff working groups

AU - Sis, B.

AU - Mengel, M.

AU - Haas, M.

AU - Colvin, R. B.

AU - Halloran, P. F.

AU - Racusen, L. C.

AU - Solez, K.

AU - Baldwin, W. M.

AU - Bracamonte, E. R.

AU - Broecker, V.

AU - Cosio, F.

AU - Demetris, A. J.

AU - Drachenberg, C.

AU - Einecke, G.

AU - Gloor, J.

AU - Glotz, D.

AU - Kraus, E.

AU - Legendre, C.

AU - Liapis, H.

AU - Mannon, R. B.

AU - Nankivell, B. J.

AU - Nickeleit, V.

AU - Papadimitriou, J. C.

AU - Randhawa, P.

AU - Regele, H.

AU - Renaudin, K.

AU - Rodriguez, E. R.

AU - Seron, D.

AU - Seshan, S.

AU - Suthanthiran, Manikkam

AU - Wasowska, B. A.

AU - Zachary, A.

AU - Zeevi, A.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.

AB - The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.

KW - Acute allograft rejection

KW - Acute cellular rejection

KW - Acute rejection

KW - Allograft rejection

KW - Antibody mediated rejection

KW - Banff

KW - Banff lesions

KW - Banff schema

KW - Chronic allograft rejection

KW - Classification

KW - Donor specific antibody

KW - GeneChip

KW - Genomic markers

UR - http://www.scopus.com/inward/record.url?scp=75749119257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749119257&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2009.02987.x

DO - 10.1111/j.1600-6143.2009.02987.x

M3 - Article

C2 - 20121738

AN - SCOPUS:75749119257

VL - 10

SP - 464

EP - 471

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 3

ER -